List of Forteo drug patents

Forteo is owned by Lilly.

Forteo contains Teriparatide.

Forteo has a total of 1 drug patent out of which 0 drug patents have expired.

Forteo was authorised for market use on 26 November, 2002.

Forteo is available in solution;subcutaneous dosage forms.

The generics of Forteo are possible to be released after 25 March, 2025.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7517334 LILLY Medication dispensing apparatus with spring-driven locking feature enabled by administration of final dose
Mar, 2025

(2 years from now)

Drugs and Companies using TERIPARATIDE ingredient

Market Authorisation Date: 26 November, 2002

Treatment: NA

Dosage: SOLUTION;SUBCUTANEOUS

How can I launch a generic of FORTEO before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic